Accenture Expands Platform for Drug Discovery and Innovation with Creation of Life Sciences Partner Ecosystem

NEW YORK and LAS VEGAS; Nov. 26, 2018 – Accenture (NYSE: ACN) has created an open partner ecosystem designed to help independent software vendors (ISVs) and life sciences companies team more effectively to accelerate drug discovery efforts and, ultimately, improve patient outcomes.
November 26, 2018

Accenture Named a Leader in IDC MarketScape Report on Oracle Worldwide Implementation Services Ecosystem

NEW YORK; Nov. 26, 2018 – Accenture (NYSE: ACN) is positioned as a Leader in the IDC MarketScape: “Worldwide Oracle Implementation Services Ecosystem 2018 Vendor Assessment.”
November 26, 2018